Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine
Schlenk, R. F., Weber, D., Herr, W., Wulf, G., Salih, H. R., Derigs, H. G., Kuendgen, A., Ringhoffer, M., Hertenstein, B., Martens, U. M., Grießhammer, M., Bernhard, H., Krauter, J., Girschikofsky, M., Wolf, D., Lange, E., Westermann, J., Koller, E., Kremers, S., Wattad, M., Heuser, M., Thol, F., Göhring, G., Haase, D., Teleanu, V., Gaidzik, V., Benner, A., Döhner, K., Ganser, A., Paschka, P. and Döhner, H. (2019) Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine. Leukemia 33 (8), pp. 1923-1933.Date of publication of this fulltext: 03 Sep 2021 09:55
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Leukemia | ||||
| Publisher: | Nature | ||||
|---|---|---|---|---|---|
| Place of Publication: | LONDON | ||||
| Volume: | 33 | ||||
| Number of Issue or Book Chapter: | 8 | ||||
| Page Range: | pp. 1923-1933 | ||||
| Date | 2019 | ||||
| Institutions | Medicine > Abteilung für Pädiatrische Hämatologie, Onkologie und Stammzelltransplantation | ||||
| Identification Number |
| ||||
| Keywords | ACUTE MYELOID-LEUKEMIA; OLDER PATIENTS; DOSE CYTARABINE; GENE-MUTATIONS; RETINOIC ACID; AML; CHEMOTHERAPY; DECITABINE; DIAGNOSIS; RECOMMENDATIONS; | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 48402 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric